NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









New Phase

New Phase

Private
IsraelHealthcare & Life Scienceshttps://newphase.co.il/

Last Round

Seed

Oct 22, 2025

Total Funding Raised

$35M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

New Phase is a biotechnology company that has developed a therapeutic technology based on nanoparticles designed to treat metastatic solid tumors.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Advanced Materials

Business Model

B2B

Customer Profile

Hardware + Subscription, Usage-Based SaaS, Government Contracts, Hardware Sales

AI Layer

Non-AI

Keywords

nanotechnology cancer treatmentmetastatic cancer treatmentsolid tumor treatmentmagnetic hyperthermiathermal ablationcancer nanomedicinenanoparticle therapymedtechmedical deviceoncology technologyminimally invasive therapyclinical stage

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

New Phase Comparables

Compare New Phase with similar companies based on industry and business-model similarity.

New Phase comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Nanotherm Therapeutics, Inc.
84%
MagHeals
81%
Sona Nanotech
81%

New Phase Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedOct 22, 2025
GrantJan 19, 2023

Key People

Founding team and executive leadership

Ofer Shalev

Founder & CEO Nanotechnology & Nanomaterials Expert

Founding Team

New Phase Investors

Notable investors and investment history

New Phase investors
InvestorRounds
BIRD FoundationGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 20, 2026

    Monthly visitors grew 36% MoM.

  • Jan 5, 2026

    Monthly visitors increased 48% MoM.

New Phase Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

New Phase Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about New Phase's valuation, stock price, and market status.

Firmographic Details

HeadquartersIsrael
Employee Range27
Year Founded2013
Last FundingOct 22, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.